Physician profile
John J Britton
NPI 1801865167
$768.38
in general payments reported to CMS, 2019-2025
12 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $132 · 2021: $247 · 2023: $106 · 2024: $69.05 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $287.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $211.29 | 2019-2021 | |
| Daiichi Sankyo INC. | $121.40 | 2021-2023 | Injectafer |
| Neotract INC. | $102.17 | 2020 | |
| Novo Nordisk INC | $98.56 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $85.54 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $54.82 | 2024-2025 | |
| Coloplast Corp | $24.20 | 2024 | |
| Janssen Biotech, INC. | $16.19 | 2025 | Carvykti, Rybrevant |
| Endo Pharmaceuticals INC. | $14.72 | 2020 | |
| Cook Medical LLC | $14.62 | 2020 | |
| Mylan Pharmaceuticals INC. | $12.94 | 2021 | |
| Merck Sharp & Dohme LLC | $11.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Britton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.